First Financial Corp’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-200
Closed -$18.4K – 386
2023
Q2
$18.4K Hold
200
– – 0.01% 275
2023
Q1
$20.7K Hold
200
– – 0.01% 266
2022
Q4
$23.1K Hold
200
– – 0.01% 259
2022
Q3
$22K Hold
200
– – 0.01% 255
2022
Q2
$36K Hold
200
– – 0.02% 231
2022
Q1
$34K Hold
200
– – 0.02% 242
2021
Q4
$42K Hold
200
– – 0.03% 229
2021
Q3
$39K Hold
200
– – 0.03% 223
2021
Q2
$57K Hold
200
– – 0.04% 199
2021
Q1
$42K Hold
200
– – 0.03% 219
2020
Q4
$39K Hold
200
– – 0.03% 224
2020
Q3
$33K Hold
200
– – 0.03% 223
2020
Q2
$28K Hold
200
– – 0.02% 229
2020
Q1
$13K Hold
200
– – 0.01% 261
2019
Q4
$22K Buy
+200
New +$19.4K 0.02% 260

Other funds holding MED

First Financial Corp's MED Position: Q3 2023 in Review

First Financial Corp sold out of Medifast (MED) in Q3 2023, closing a stake of 200 shares — an estimated $18.4K sold.

First Financial Corp first reported a position in MED in Q4 2019 and held it in 15 quarters. The position peaked at $57K in Q2 2021. 223 funds tracked by Wall St. Rank hold MED as of Q3 2023.

  • First Financial Corp reported no remaining Medifast position as of Q3 2023 after selling out during the quarter.
  • First Financial Corp sold 200 Medifast shares in Q3 2023, an estimated $18.4K.
  • First Financial Corp first reported a position in Medifast in Q4 2019 and held it in 15 quarters.
  • First Financial Corp's Medifast position peaked at $57K in Q2 2021.
  • 223 funds tracked by Wall St. Rank held Medifast as of Q3 2023.

Based on First Financial Corp's 13F filing for Q3 2023, filed 11 Oct 2023.